Telomerase activity during cardiac development

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 10, 1997, Pages 2717-2724

  Borges, Adolfo ^a   Liew, Choong Chin ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Development; Enzyme regulation; Heart; Rat; Telomerase

Indexed keywords

TELOMERASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FETUS; HEART DEVELOPMENT; HEART MUSCLE CELL; LIVER; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031258792     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0503     Document Type: Article

References (35)

1. ANVERSA P, PALACKAL T, SONNENBLICK EH, OLIVETTI G, CAPASSO JM, 1990. Hypertensive cardiomyopathy: myocyte nuclei hyperplasia in the mammalian rat heart. J Clin Invest 85: 994-997.
2. BESTILNY L, BROWN CB, MIURA Y, ROBERTSON LD, RIABOWOL KT, 1996. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res 56: 3796-3802.
3. BLASCO MA, FUNK W, VILLEPONTEAU B, GREIDER CW, 1995. Functional characterization and developmental regulation of mouse telomerase RNA. Science 269: 1267-1270.
4. BRADFORD MM, 1976. A rapid and sensitive method for the quantitation of micrograms quantities of protein utilizing the principle of protein-dye staining. Anal Biochem 72: 248-254.
5. CHADENEAU C, SIEGEL P, HARLEY CB, MULLER WJ, BACHETTI S, 1995. Telomerase activity in normal and murine tissues. Oncogene 11: 893-898.
6. CLAYCOMB WC, 1977. Cardiac-muscle hypertrophy. Differentiation and growth of the heart cell during development. Biochem J 168: 599-601.
7. CLAYCOMB WC, 1992. Control of cardiac muscle cell division. Trends Cardiovasc Med 2: 231-236.
8. DE LANGE T, 1994. Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 91: 2882-2885.
9. DZAU VJ, KRIEGER JE, HUTCHINSON H, 1995. Molecular mechanisms in hypertension. In: Haber E (ed.). Molecular Cardiovascular Medicine. New York: Scientific American, 225-241.
10. GREIDER CW, 1996. Telomere length regulation. Ann Rev Biochem 65: 337-365.
11. GU W, SCHNEIDER JW, CONDORELLI G, KAUSHAL S, MAHDAVI V, NADAL-GINARD B, 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72: 309-324.
12. HÄRLE-BACHOR C, BOUKAMP P, 1996. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93: 6476-6481.
13. HARLEY CB, VILLEPONTEAU B, 1995. Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 5: 249-255.
14. HIYAMA K, HIRAI Y, KYOIZUMI S, AKIYAMA M, HIYAMA E, PIATYSZEK MA, SHAY JW, ISHIOKA S, YAMAKIDO M, 1995. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711-3715.
15. HOLT SE, WRIGHT WE, SHAY JW, 1996. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16: 2932-2939.
16. KIM NW, PIATYSZEK MA, PROWSE KR, HARLEY CB, WEST MD, HO PL, COVIELLO GM, WRIGHT WE, WEINRICH SL, SHAY JW, 1994. Specific association of human telomerase activity with immortal cell lines and cancer. Science 266: 2011-2015.
17. MARINO TA, HALDAR S, WILLIAMSON EC, BEAVERSON K, WALTER RA, MARINO DR, LIPSON KE, 1991. Proliferating cell nuclear antigen in developing and adult rat cardiac muscle cells. Circ Res 69: 1353-1360.
18. MARTELLI F, CENCIARELLI C, SANTARELLI G, POLIKAR B, FELSANI A, CARUSO M, 1994. MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene 9: 3579-3590.
19. MCGILL CJ, BROOKS G, 1995. Cell cycle control mechanisms and their role in cardiac growth. Cardiovasc Res 30: 557-569.
20. NGUYEN HT, MEDFORD RM, NADAL-GINARD B, 1983. Reversibility of muscle differentiation in the absence of commitment: analysis of a myogenic cell line temperature-sensitive for commitment. Cell 34: 281-293.
21. OLIVETTI G, RICCI R, ANVERSA P, 1987. Hyperplasia of myocyte nuclei in long-term cardiac hypertrophy in rats. J Clin Invest 80: 1818-1821.
22. OLOVNIKOV AM, 1973. A theory of marginotomy. J Theor Biol 41: 189-190.
23. PIATYSZEK MA, KIM NW, WEINRICH SL, HIYAMA K, HIYAMA E, WRIGHT WE, SHAY JW, 1995. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol. Meth Cell Sci 17: 1-15.
24. PROWSE KR, GREIDER CW, 1996. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 92: 4818-4822.
25. RAKUSAN K, 1984. In: Zak R (ed.). Growth of the Heart in Health and Disease. New York: Raven Press Publishers, 131-164.
26. RUMYANTSEV PP, 1977. Interrelations of the proliferation and differentiation processes during cardiac myogenesis and regeneration. Int Rev Cytol 51: 186-273.
27. SHARMA HW, SOKOLOSKI JA, PEREZ JR, MALTESE JY, SARTORELLI AC, STEIN CA, NICHOLS G, KHALED Z, TELANG NT, NARAYANAN R, 1995. Differentiation of immortal cells inhibits telemerase activity. Proc Natl Acad Sci USA 92: 12343-12346.
28. SKERJANC IS, MCBURNEY MW, 1994. The E box is essential for activity of the cardiac actin promoter in skeletal but not in cardiac muscle. Dev Biol 163: 125-132.
29. TAHARA H, NAKANISHI M, KITAMOTO R, NAKASHIO R, SHAY JW, TAHARA E, KAKIYAMA G, IDE T, 1995. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 55: 2734-2736.
30. TAYLOR RS, RAMIREZ RD, OGOSHI M, CHAFFINS M, PIATYSZEK MA, SHAY JW, 1996. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 106: 759-765.
31. UENO H, PERRYMAN MB, ROBERTS R, SCHNEIDER MD, 1988. Differentiation of cardiac myocytes after mitogen withdrawal exhibits three sequential states of the ventricular growth response. J Cell Biol 107: 1911-1918.
32. WATSON JD, 1972. Origin of concatameric T4 DNA. Nature 239: 197-201.
33. WRIGHT WE, PIATYSZEK MA, RAINEY WE, BYRD W, SHAY JW, 1996. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173-179.
34. ZAK R, 1995. Molecular mechanisms of cardiac hypertrophy. In: Haber E (ed.). Molecular Cardiovascular Medicine. New York: Scientific American, 177-192.
35. ZHU X, KUMAR R, MANDAL M, SHARMA N, SHARMA H, DHINGRA U, SOKOLOSKI JA, HSIAO R, NARAYANAN R, 1996. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci USA 93: 6091-6095.